. Author manuscript; available in PMC: 2023 Apr 1.

Published in final edited form as: J Am Coll Health. 2020 Jul 1;70(3):830–836. doi: 10.1080/07448481.2020.1775605

Table 2.

Mediation Analyses Involving EF, Medication Management, Appointment Keeping, Talking with Providers, and Health Tracking

	Path A	Path B	Path C	Path C’	Mediated Effect (AXB)	95% CI for Mediated Effect
	(b, SE)	(b, SE)	(b, SE)	(b, SE)	(b, SE)
EF—Medication—Transition Readiness	−.01 (.004)^*	.17 (0.06)^*	−.02 (.004)^*	−.01 (.004)^*	−.002 (.001)^*	−.005, −.001
EF—Appointment—Transition Readiness	−.01 (.004)^*	.32 (.08)^*	−.02 (.004)^*	−.01 (.004)^*	−.005 (.002)^*	−.009, −.002
EF—Talking—Transition Readiness	−.01 (.003)^*	−.05 (.08)	−.02 (.004)^*	−.01 (.004)^*	.0004 (.001)	−.001, .002
EF—Tracking—Transition Readiness	−.01 (.004)^*	.02 (.07)	−.02 (.004)^*	−.01 (.004)^*	−.0002 (.001)	−.002, .001

Note. All path coefficients are unstandardized. Path A = effect of EF on mediator. Path B = effect of mediator on Transition Readiness controlling for EF. Path C = total effect. Path C’ = direct effect of EF on transition readiness. The mediation model includes age, sex, and transfer status as covariates.

path is significant at p<0.05.